首页> 外文OA文献 >Sofosbuvir and Ledipasvir/Sofosbuvir for the treatment of patients with Chronic Genotype 6 Hepatitis C Virus Infection: integrated analysis of Phase 2 and Phase 3 studies

【2h】

Sofosbuvir and Ledipasvir/Sofosbuvir for the treatment of patients with Chronic Genotype 6 Hepatitis C Virus Infection: integrated analysis of Phase 2 and Phase 3 studies

机译：sofosbuvir和Ledipasvir / sofosbuvir用于治疗慢性基因型6型丙型肝炎病毒感染患者：2期和3期研究的综合分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Poster Session 2: Hepatitis C: Therapeutics (Approved Agents): no. 1120

机译：张贴者会议2：丙型肝炎：治疗剂（批准代理人）：否。 1120

著录项

作者
Chuang, WL; Gane, EJ; Hyland, RH; Yang, JC; Mo, H; Brainard, DM; Knox, SJ; McHutchison, JG; Lai, CL; Chan, HLY; Gao, B; Lawitz, E; Kowdley, KV; Hassanein, TI; De-Oertel, S;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus [J] . Lim Young-Suk, Ahn Sang Hoon, Lee Kwan Sik, Hepatology international . 2016,第6期

机译：ledipasvir / sofosbuvir固定剂量联合片剂的IIIb期研究在初治和经验丰富的韩国慢性感染基因1型丙型肝炎患者中的应用
2. A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na?ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus [J] . Young-Suk Lim, Sang Hoon Ahn, Kwan Sik Lee, Hepatology international . 2016,第6期

机译：利地帕韦/索非布韦固定剂量联合片剂在初治和经验丰富的韩国慢性感染基因1型丙型肝炎患者中的IIIb期研究
3. Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials [J] . Alqahtani Saleh A., Afdhal Nezam, Zeuzem Stefan, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2015,第1期

机译：联合利巴韦林和不联合利巴韦林的ledipasvir / sofosbuvir在慢性丙型肝炎病毒基因型1感染患者中的安全性和耐受性：ION III期临床试验的分析
4. DIFFERENTIAL HUMORAL RESPONSE OF GENOTYPE IB HEPATITIS C VIRUS F PROTEIN BETWEEN CHRONIC AND RECOVERED INFECTIONS [C] . Deng Xiaozhao, Kong Jing, Chu Chunli, Progress on post-genome technologies and modern natural products . 2011

机译：慢性感染和康复感染之间基因型IB型肝炎C病毒F蛋白的差异性尿液反应
5. Population pharmacokinetics and efficacy of ribavirin in patients with chronic hepatitis C genotype 1 infection. [D] . Jin, Runyan. 2010

机译：利巴韦林在慢性丙型肝炎基因型1感染患者中的群体药代动力学和功效。
6. The Efficacy and Safety of 12 Weeks of Sofosbuvir and Ledipasvir versus Sofosbuvir Ledipasvir and Ribavirin in Patients with Chronic Hepatitis C Genotype 1 Who Have Cirrhosis and Have Failed Prior Therapy: A Systematic Review and Meta-Analysis [O] . William Stokes, Carol Fenton, Fiona Clement, 2017

机译：Sofosbuvir和Ledipasvir对比SofosbuvirLedipasvir和Ribavirin治疗慢性丙型肝炎肝硬化且治疗失败的患者12周的疗效和安全性：系统评价和荟萃分析
7. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials [O] . Yasuhiro Asahina, Chun‐Jen Liu, Edward Gane, 2020

机译：12周的Leedipasvir / Sofosbuvir全口服患者慢性丙型肝炎基因型2感染：综合分析三种临床试验

Sofosbuvir and Ledipasvir/Sofosbuvir for the treatment of patients with Chronic Genotype 6 Hepatitis C Virus Infection: integrated analysis of Phase 2 and Phase 3 studies

摘要

著录项

相似文献

相关主题

期刊订阅